- Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib
- Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib
- Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
As of last trade
Pharming Group NV (PHGN:DEU) traded at 1.20, -6.69% below its 52-week high of 1.29, set on Aug 25, 2022.
0.61Dec 06 20211.29Aug 25 2022
Markit short selling activity
|Market cap||781.20m EUR|
|EPS (TTM)||0.0407 |
Data delayed at least 15 minutes, as of Dec 05 2022 12:15 GMT.